June 2026 - Page 2 of 5

How are AI and protein folding tools accelerating drug discovery?

16

Jun

why AI is the key to faster protein folding and drug discovery

Drug discovery has long been a slow, costly, and high‑stakes endeavor, often requiring more than ten years and enormous financial investment before a single therapy reaches the market. Breakthroughs in artificial intelligence and protein folding tools are now transforming this process by greatly enhancing how researchers interpret biological targets, craft potential drug molecules, and anticipate their effects. As these innovations advance, development timelines are shrinking, expenses are decreasing, and therapeutic possibilities once considered unattainable are becoming viable.The Central Role of Protein Structure in Drug DiscoveryMost drugs work by binding to proteins and altering their activity. To design effective molecules, researchers…

How do companies quantify reputational risk in valuation models?

16

Jun

By demo

Investments and Business

Integrating stakeholder perception into financial valuation frameworks

Reputational risk refers to the potential loss in value that a company may experience when stakeholders’ perceptions deteriorate due to real or perceived events. These events can include ethical failures, regulatory breaches, product defects, data privacy incidents, or environmental harm. Because reputation influences customer trust, pricing power, employee retention, and access to capital, it has become a material factor in corporate valuation.Contemporary valuation frameworks increasingly seek to measure reputational risk rather than regard it as merely a qualitative issue, and although reputation is intangible, its financial impacts can be detected, assessed, and often prove enduring.Why It Is Essential to Quantify…

How are regulators shaping sustainable finance product design?

16

Jun

By Jean Thompson

Investments and Business

Integrating social objectives into product design via regulatory requirements

Sustainable finance has moved from niche to mainstream, and regulators are a central force behind that shift. Through disclosure mandates, classification systems, product governance rules, and supervisory guidance, authorities are actively influencing how financial products are conceived, structured, marketed, and monitored. The result is a redesign of investment funds, loans, bonds, insurance products, and advisory services to align with environmental and social objectives while protecting investors from misleading claims.Regulatory Goals Driving Sustainable Product DesignRegulators are advancing a set of interrelated objectives that have a direct impact on product design.Market integrity: Discouraging deceptive sustainability assertions while narrowing information gaps.Capital allocation: Directing…

Côte d’Ivoire: cocoa CSR with traceability and better incomes for growers

15

Jun

By demo

Social Responsibility

Aligning corporate goals with environmental outcomes in the Ivorian cocoa trade

Ivory Coast accounts for roughly 40% of global cocoa supply, producing around 2 million metric tons in recent seasons. Cocoa is central to the country’s export earnings and to the livelihoods of millions of smallholder families. At the same time, the sector faces structural challenges: low farmer incomes, persistent child labor, aging trees and low productivity, deforestation, and fragmented supply chains. Corporate social responsibility (CSR) efforts combined with modern traceability systems are increasingly positioned as the levers that can align industry profit with social and environmental outcomes.The CSR environment: regulations, corporate pledges, and key hurdlesCSR efforts in Ivory Coast are…

15

Jun

By demo

Science and Technology

how AI-driven protein folding is reducing drug discovery costs

Drug discovery has traditionally been a slow, expensive, and high-risk process, often taking more than a decade and billions of dollars to bring a single therapy to market. Recent advances in artificial intelligence and protein folding tools are reshaping this landscape by dramatically improving how scientists understand biological targets, design drug candidates, and predict outcomes. Together, these technologies are compressing timelines, lowering costs, and opening therapeutic opportunities that were previously out of reach.The Central Role of Protein Structure in Drug DiscoveryMost medications exert their effects by attaching to specific proteins and modifying how those proteins function, and creating potent molecules…

What style defines Nicolas Ghesquière at Louis Vuitton?

15

Jun

By Jean Thompson

Culture and Entertainment

Defining the Ghesquière aesthetic at Louis Vuitton

Defining the Signature Style of Nicolas Ghesquière at Louis VuittonNicolas Ghesquière, who has served as the Artistic Director of Louis Vuitton’s women’s collections since 2013, has left a singular and forward-thinking mark on the storied French maison. His creative approach for Louis Vuitton intertwines the brand’s legacy with a sharply contemporary edge, ushering in a period defined by bold innovation, futuristic structures, and narrative-driven design that draws inspiration from a wide spectrum of eras and cultures. To grasp the aesthetic that characterizes Nicolas Ghesquière at Louis Vuitton, it becomes important to explore his core stylistic principles, standout collections, and the…